Carrie Liao
Chief Accounting Officer · Definium Therapeutics, Inc.
- 2024
- Dec 27, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Carrie Liao files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert Barrow - $3.98M in DFTX purchases and sales in the last 12 months
- Mark Sullivan - $1.45M in DFTX purchases and sales in the last 12 months
- Daniel Karlin - $1.07M in DFTX purchases and sales in the last 12 months
- Brandi Roberts - $259K in DFTX purchases and sales in the last 12 months
- Matthew T. Wiley - $242K in DFTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Carrie Liao?
Carrie Liao is a corporate insider, tracked as Chief Accounting Officer of Definium Therapeutics, Inc. (DFTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Carrie Liao last file a Form 4?
The only primary Form 4 on record is dated 27 December 2024.
Has Carrie Liao been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($17K) across all tracked filings.
